OncoTracker
West Hollywood, US · Founded 2014 · Delaware corporation
ONCOtracker is an incubator-stage biotech company developing approaches for monitoring and treating patients with multiple myeloma, other B-cell malignancies, and related disorders. It is part of a family of oncology-focused companies associated with the Berenson Cancer Center in the United States.
Founders & leadership
OncoTracker was founded in 2014 by James R. Berenson.
Reported raises · per SEC filings
Form D private placements$1.3M disclosed across 3 rounds · 2015–2020
▶$150KraisedFeb 2020 · 1 investors · Other Health CareRule 506(b)
▶$150KraisedFeb 2020 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James BerensonExecutive Officer, Director, Promoter
- Thomas W. GosneyExecutive Officer
- Offering amount
- $2M
- Amount sold
- $150K
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$35KraisedMar 2019 · 1 investors · OtherRule 506(b)
▶$35KraisedMar 2019 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- James KuoExecutive Officer
- James BerensonExecutive Officer, Director, Promoter
- Offering amount
- $568.7K
- Amount sold
- $35K
- First sale
- Feb 2019
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$1.1MraisedNov 2016 · 20 investors · OtherRule 506(b)
▶$1.1MraisedNov 2016 · 20 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Geoffrey GeeExecutive Officer, Director
- James BerensonExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.1M
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlapMD Anderson Cancer Center9 shared keywordsUT MD Anderson is a cancer research and treatment center that provides patient care, conducts research, and offers education in cancer prevention and treatment. It is part of the University of Texas System and operates as a nonprofit medical institution.
Exact Sciences9 shared keywordsExact Sciences develops molecular diagnostic tests for cancer screening and detection, including multitarget stool DNA testing for colorectal cancer and multigene assays for breast cancer recurrence. The company serves patients and healthcare providers in the cancer diagnostics field.
Labcorp7 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
Topera7 shared keywordsAbbott's Lingo Glucose System is a continuous glucose monitoring device for non-insulin users aged 18+, designed to track glucose levels and support metabolic health decisions.
American Cancer Society (ACS)6 shared keywordsThe American Cancer Society is a nonprofit organization that provides cancer research updates, screening and prevention guidance, and community engagement opportunities. It serves individuals seeking cancer information and those who want to support cancer research and patient advocacy efforts.
Companies competing with OncoTracker for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does OncoTracker do?
- ONCOtracker is an incubator-stage biotech company developing approaches for monitoring and treating patients with multiple myeloma, other B-cell malignancies, and related disorders. It is part of a family of oncology-focused companies associated with the Berenson Cancer Center in the United States.
- Who founded OncoTracker?
- OncoTracker was founded by James R. Berenson in 2014.
- How much funding has OncoTracker raised?
- OncoTracker has disclosed $1.3M raised across 3 rounds.
- Where is OncoTracker headquartered?
- OncoTracker is headquartered in West Hollywood, US.